Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
Home
Pharma Solutions
IVD Solutions
Portfolio
About Us
Management team
Meet the ADx Team
News and Media
Upcoming events
Contact
search
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
Lashuel et al.
NPJ Parkinsons Dis.
2022 Oct;8(1):136.
Previous Post
Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease
Next Post
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
Share
Share
Close Menu
Home
Pharma Solutions
IVD Solutions
Portfolio
About Us
Management team
Meet the ADx Team
News and Media
Upcoming events
Contact
